L931-0721 Screening compound: 4-benzyl-2-[4-(2-cyclohexylacetyl)piperazin-1-yl]-3H,4H-pyrido[2,3-b]pyrazin-3-one

L931-0721 Screening compound: 4-benzyl-2-[4-(2-cyclohexylacetyl)piperazin-1-yl]-3H,4H-pyrido[2,3-b]pyrazin-3-one
L931-0721 Screening compound: 4-benzyl-2-[4-(2-cyclohexylacetyl)piperazin-1-yl]-3H,4H-pyrido[2,3-b]pyrazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L931-0721
4-benzyl-2-[4-(2-cyclohexylacetyl)piperazin-1-yl]-3H,4H-pyrido[2,3-b]pyrazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L931-0721

Molecular Formula

C26H31N5O2 (C26 H31 N5 O2)

Compound Name

4-benzyl-2-[4-(2-cyclohexylacetyl)piperazin-1-yl]-3H,4H-pyrido[2,3-b]pyrazin-3-one

IUPAC name

4-benzyl-2-[4-(2-cyclohexylacetyl)piperazin-1-yl]-3H4H-pyrido[23-b]pyrazin-3-one

SMILES

O=C(CC1CCCCC1)N(CC1)CCN1C1=Nc2cccnc2N(Cc2ccccc2)C1=O

InChI

InChI=1S/C26H31N5O2/c32-23(18-20-8-3-1-4-9-20)29-14-16-30(17-15-29)25-26(33)31(19-21-10-5-2-6-11-21)24-22(28-25)12-7-13-27-24/h2,5-7,10-13,20H,1,3-4,8-9,14-19H2

InChI Key

KRJFDFXXIWKWSK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27487962

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

445.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.823

Distribution Coefficient, logD

3.823

Water Solubility, LogSw

-4.05

Polar Surface Area

52.672

Acid Dissociation Constant (pKa)

23.25

Base Dissociation Constant (pKb)

3.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

L931-0721 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L931-0721 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L931-0721?
Check Price and Availability of L931-0721, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L931-0721 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L931-0721
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L931-0721
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L931-0721 available by request